ArticleClinical case reports2025
Unusual Presentation of Subcutaneous Panniculitis-Like T-Cell Lymphoma.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unusual Presentation of Subcutaneous Panniculitis-Like T-Cell Lymphoma.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare variant of primary cutaneous T-cell lymphoma primarily affecting subcutaneous adipose tissue and mimicking lobular panniculitis. It often presents with erythematous subcutaneous nodules or plaques, and diagnosis can be challenging due to its diverse clinical manifestations. We report an unusual presentation of SPTCL in a 40-year-old female with recurrent, painless ulcerated plaques on the thighs and lower legs, accompanied by systemic symptoms including weight loss, fatigue, and laboratory abnormalities. Initially misdiagnosed as erythema nodosum, the patient was treated with antibiotics and corticosteroids without significant improvement. Histopathology and immunohistochemistry from skin biopsies revealed atypical lymphocytic infiltration consistent with SPTCL (CD3+, CD30+, CD4+, CD8-, CD56-). This case adds to the spectrum of SPTCL presentations, emphasizing the importance of considering SPTCL in panniculitis-like lesions refractory to conventional treatment. Prompt histopathological evaluation with immunophenotyping is crucial for early diagnosis and appropriate management to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.